Michael C. Henry

Array ( [id] => 6507156 [patent_doc_number] => 20100210573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'COMPOUND AND COMPOSITIONS FOR TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 12/641891 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7801 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210573.pdf [firstpage_image] =>[orig_patent_app_number] => 12641891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599996 [patent_doc_number] => 20100098642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'OPTIMISED FORMULATION OF TOBRAMYCIN FOR AEROSOLIZATION' [patent_app_type] => utility [patent_app_number] => 12/642336 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3708 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098642.pdf [firstpage_image] =>[orig_patent_app_number] => 12642336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227553 [patent_doc_number] => 08633221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Method of enhancing lysosomal α-galactosidase A' [patent_app_type] => utility [patent_app_number] => 12/624026 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5433 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12624026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289372 [patent_doc_number] => 20100158796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'AMIDES OF HYALURONIC ACID AND THE DERIVATIVES THEREOF AND A PROCESS FOR THEIR PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/623253 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6166 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158796.pdf [firstpage_image] =>[orig_patent_app_number] => 12623253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222634 [patent_doc_number] => 20100056473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'METHOD OF EXTRACTING FUCOIDAN' [patent_app_type] => utility [patent_app_number] => 12/617564 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3380 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056473.pdf [firstpage_image] =>[orig_patent_app_number] => 12617564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222644 [patent_doc_number] => 20100056476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING PERANHYDROCYCLODEXTRIN' [patent_app_type] => utility [patent_app_number] => 12/617074 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4166 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056476.pdf [firstpage_image] =>[orig_patent_app_number] => 12617074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552276 [patent_doc_number] => 08759322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Hyaluronic acid derivative and pharmaceutical composition thereof' [patent_app_type] => utility [patent_app_number] => 13/127582 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 37146 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359825 [patent_doc_number] => 20120214986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'PROCESS FOR THE PREPARATION OF IRON (III) CARBOXYMALTOSE COMPLEX' [patent_app_type] => utility [patent_app_number] => 13/505115 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5147 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026571 [patent_doc_number] => 08536153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Chemical synthesis of phosphatidylinositol mannoside glycans from Mycobacterium tuberculosis' [patent_app_type] => utility [patent_app_number] => 13/127320 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12114 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320482 [patent_doc_number] => 20100113377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Method of Treatment Using Alpha-1-Adrenergic Agonist Compounds' [patent_app_type] => utility [patent_app_number] => 12/610720 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4479 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113377.pdf [firstpage_image] =>[orig_patent_app_number] => 12610720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989631 [patent_doc_number] => 09034834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-19 [patent_title] => 'Antiviral supplement formulations' [patent_app_type] => utility [patent_app_number] => 12/609120 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14251 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12609120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16969376 [patent_doc_number] => 11065323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-20 [patent_title] => Purification method [patent_app_type] => utility [patent_app_number] => 13/126146 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12947 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6367550 [patent_doc_number] => 20100074856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'EXTERNAL PREPARATION COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/605294 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9748 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074856.pdf [firstpage_image] =>[orig_patent_app_number] => 12605294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6349330 [patent_doc_number] => 20100021554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'METHOD FOR PREVENTION AND TREATMENT OF REFLUX INJURY IN THE AERODIGESTIVE TRACT AND LARYNGOPHARYNX CAUSED BY PEPSIN' [patent_app_type] => utility [patent_app_number] => 12/575366 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2000 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021554.pdf [firstpage_image] =>[orig_patent_app_number] => 12575366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377751 [patent_doc_number] => 20100081626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'WEIGHT LOSS COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/567323 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3625 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081626.pdf [firstpage_image] =>[orig_patent_app_number] => 12567323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401918 [patent_doc_number] => 08691971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference' [patent_app_type] => utility [patent_app_number] => 13/120409 [patent_app_country] => US [patent_app_date] => 2009-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 31914 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102594 [patent_doc_number] => 20110166087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR USE IN TREATING SEXUALLY TRANSMITTED INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/062182 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3428 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166087.pdf [firstpage_image] =>[orig_patent_app_number] => 13062182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026890 [patent_doc_number] => 20110054155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Novel Environmentally Friendly Technology for Production of Ginsenoside Re' [patent_app_type] => utility [patent_app_number] => 12/549444 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1834 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054155.pdf [firstpage_image] =>[orig_patent_app_number] => 12549444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102608 [patent_doc_number] => 20110166101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'MICROPARTICLES' [patent_app_type] => utility [patent_app_number] => 13/061316 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7769 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166101.pdf [firstpage_image] =>[orig_patent_app_number] => 13061316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937402 [patent_doc_number] => 20110212907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'HEXADECASACCHARIDES WITH ANTITHROMBOTIC ACTIVITY, INCLUDING A COVALENT BOND AND AN AMINO CHAIN' [patent_app_type] => utility [patent_app_number] => 13/060745 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4166 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212907.pdf [firstpage_image] =>[orig_patent_app_number] => 13060745 [rel_patent_id] =>[rel_patent_doc_number] =>)